Nancy Valente

Director, Myovant Sciences Ltd.

Companies

Xencor IncEVP, Chief Development Officer May 3, 2023 to now¹
Myovant Sciences Ltd.Board member Nov 9, 2021 to Mar 10, 2023²
Xencor IncBoard member Sep 9, 2022 to Sep 9, 2022³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARXencor Inc, EVP, Chief Development Officer
2
SEC EDGARMyovant Sciences Ltd., Board member
3
SEC EDGARXencor Inc, Board member